Japan Colorectal Cancer Drugs Therapeutic Market (2025-2031) | Demand, Revenue, Challenges, Strategic Insights, Competitive, Value, Consumer Insights, Restraints, Investment Trends, Segmentation, Competition, Trends, Pricing Analysis, Share, Growth, Outlook, Strategy, Size, Analysis, Drivers, Forecast, Supply, Industry, Segments, Opportunities, Companies

Market Forecast By Drug Class (Immunotherapy, Chemotherapy, Others), By Route of Administration (Oral, Intravenous, Intramuscular, Subcutaneous, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And Competitive Landscape
Product Code: ETC11626066 Publication Date: Apr 2025 Updated Date: Oct 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Bhawna Singh No. of Pages: 65 No. of Figures: 34 No. of Tables: 19

Japan Colorectal Cancer Drugs Therapeutic Market Import Shipment by Countries (Top 5) & Competition (HHI)

In 2024, Japan continued to import colorectal cancer drugs primarily from Germany, Switzerland, USA, Italy, and Metropolitan France. Despite a negative Compound Annual Growth Rate (CAGR) of -5.32% from 2020 to 2024, the market experienced a slightly less decline with a growth rate of -3.46% from 2023 to 2024. The Herfindahl-Hirschman Index (HHI) indicated low concentration among the top exporting countries, suggesting a diverse import market for colorectal cancer drugs in Japan. Monitoring these trends is crucial for stakeholders in the pharmaceutical industry to understand the evolving landscape and potential opportunities for growth.

Japan Colorectal Cancer Drugs Therapeutic Market Import Shipment by Countries (Top 5) & Competition (HHI)

Key Highlights of the Report:

  • Japan Colorectal Cancer Drugs Therapeutic Market Outlook
  • Market Size of Japan Colorectal Cancer Drugs Therapeutic Market, 2024
  • Forecast of Japan Colorectal Cancer Drugs Therapeutic Market, 2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Revenues & Volume for the Period 2021-2031
  • Japan Colorectal Cancer Drugs Therapeutic Market Trend Evolution
  • Japan Colorectal Cancer Drugs Therapeutic Market Drivers and Challenges
  • Japan Colorectal Cancer Drugs Therapeutic Price Trends
  • Japan Colorectal Cancer Drugs Therapeutic Porter's Five Forces
  • Japan Colorectal Cancer Drugs Therapeutic Industry Life Cycle
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Drug Class for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Immunotherapy for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Chemotherapy for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Others for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Route of Administration for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Oral for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Intravenous for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Intramuscular for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Subcutaneous for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Distribution Channel for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Hospital Pharmacies for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Retail Pharmacies for the Period 2021-2031
  • Historical Data and Forecast of Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume By Online Pharmacies for the Period 2021-2031
  • Japan Colorectal Cancer Drugs Therapeutic Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Channel
  • Japan Colorectal Cancer Drugs Therapeutic Top Companies Market Share
  • Japan Colorectal Cancer Drugs Therapeutic Competitive Benchmarking By Technical and Operational Parameters
  • Japan Colorectal Cancer Drugs Therapeutic Company Profiles
  • Japan Colorectal Cancer Drugs Therapeutic Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Japan Colorectal Cancer Drugs Therapeutic Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Japan Colorectal Cancer Drugs Therapeutic Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Japan Colorectal Cancer Drugs Therapeutic Market Overview

3.1 Japan Country Macro Economic Indicators

3.2 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, 2021 & 2031F

3.3 Japan Colorectal Cancer Drugs Therapeutic Market - Industry Life Cycle

3.4 Japan Colorectal Cancer Drugs Therapeutic Market - Porter's Five Forces

3.5 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 Japan Colorectal Cancer Drugs Therapeutic Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence and prevalence of colorectal cancer in Japan

4.2.2 Advancements in drug development and targeted therapies for colorectal cancer

4.2.3 Growing awareness and screening programs for early detection of colorectal cancer

4.3 Market Restraints

4.3.1 Stringent regulatory approval processes for new colorectal cancer drugs in Japan

4.3.2 High costs associated with innovative colorectal cancer drugs

4.3.3 Competition from generic drug manufacturers impacting pricing and market share

5 Japan Colorectal Cancer Drugs Therapeutic Market Trends

6 Japan Colorectal Cancer Drugs Therapeutic Market, By Types

6.1 Japan Colorectal Cancer Drugs Therapeutic Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Drug Class, 2021 - 2031F

6.1.3 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F

6.1.4 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F

6.1.5 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F

6.2 Japan Colorectal Cancer Drugs Therapeutic Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Oral, 2021 - 2031F

6.2.3 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intravenous, 2021 - 2031F

6.2.4 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intramuscular, 2021 - 2031F

6.2.5 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Subcutaneous, 2021 - 2031F

6.2.6 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F

6.3 Japan Colorectal Cancer Drugs Therapeutic Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F

6.3.3 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F

6.3.4 Japan Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F

7 Japan Colorectal Cancer Drugs Therapeutic Market Import-Export Trade Statistics

7.1 Japan Colorectal Cancer Drugs Therapeutic Market Export to Major Countries

7.2 Japan Colorectal Cancer Drugs Therapeutic Market Imports from Major Countries

8 Japan Colorectal Cancer Drugs Therapeutic Market Key Performance Indicators

8.1 Patient survival rates post-treatment with colorectal cancer drugs

8.2 Adoption rates of new colorectal cancer drugs in Japan

8.3 Number of research studies and clinical trials focused on colorectal cancer drugs

8.4 Investment in research and development by pharmaceutical companies for colorectal cancer drugs

8.5 Patient adherence and compliance to prescribed colorectal cancer drug regimens

9 Japan Colorectal Cancer Drugs Therapeutic Market - Opportunity Assessment

9.1 Japan Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Japan Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Japan Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 Japan Colorectal Cancer Drugs Therapeutic Market - Competitive Landscape

10.1 Japan Colorectal Cancer Drugs Therapeutic Market Revenue Share, By Companies, 2024

10.2 Japan Colorectal Cancer Drugs Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All